Enveric Biosciences ENVB
NASDAQ ENVB
$1.43 +0.04 (+2.88%)
At close: Aug 21, 2026 · 4:00 PM EDT

Enveric Biosciences (ENVB) Change in Taxes (2014 - 2015)

Enveric Biosciences (ENVB) posted Change in Taxes of $43425.0 for Q2 2015, down 72.56% sequentially from $158235.0 in Q2 2014, and down 72.56% YoY from $158235.0 in Q2 2014.

Enveric Biosciences (ENVB) Change in Taxes (2014 - 2015) Analysis & Trends

Enveric Biosciences has reported Change in Taxes for 2 years, with the latest figure at $43425.0 in Q2 2015.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Taxes (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn -
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn -
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn -
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn -
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn -
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn 90.33 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn -
9 Royalty Pharma 27.27 Bn 26.43 Bn - -
10 Enveric Biosciences 5.66 Mn -2.64 Mn - -

Historic Data

Download Data
DateValue
Jun 30, 2015 43,425.00
Jun 30, 2015 43,425.00
Jun 30, 2014 158,235.00
Jun 30, 2014 158,235.00